Evidence for an oncogenic potential of the Epstein-Barr virus.
D000818:Animals; D000956:Antigens, Viral; D002051:Burkitt Lymphoma / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D007244:Infectious Mononucleosis / Q000097:blood / Q000276:immunology; D008213:Lymphocyte Activation; D008854:Microscopy, Electron; D009303:Nasopharyngeal Neoplasms / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D009500:Neutralization Tests; D009858:Oncogenic Viruses; D014779:Virus Replication
D000956:Antigens, Viral